Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novamind Inc (OP: NVMDF ) N/A UNCHANGED Last Price Updated: 3:36 PM EDT, Jun 13, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Novamind Inc < Previous 1 2 Next > Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies December 16, 2021 Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing... Via FinancialNewsMedia Topics Artificial Intelligence Exposures Artificial Intelligence Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders December 06, 2021 Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza TORONTO, ON / ACCESSWIRE / December 6, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the... From Novamind Inc. Via AccessWire Topics Death Exposures COVID-19 Death Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6 December 02, 2021 TORONTO, ON / ACCESSWIRE / December 2, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will... From Novamind Inc. Via AccessWire Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network December 01, 2021 Strategic investment and advisory agreement enables the global expansion of Novamind's psychedelic clinic model TORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc.... From Novamind Inc. Via AccessWire Novamind Reports Fiscal Q1 Financial Results and Operating Highlights November 29, 2021 - Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice - Total revenue of $1,857,750, +113% when compared to same period last year - Total working capital of... From Novamind Inc. Via AccessWire Novamind Unveils New Logo and Invests in Unified Brand November 24, 2021 TORONTO, ON / ACCESSWIRE / November 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc Via AccessWire Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona November 16, 2021 TORONTO, ON / ACCESSWIRE / November 16, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc. Via AccessWire Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness November 15, 2021 TORONTO, ON / ACCESSWIRE / November 15, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will... From Novamind Ventures Inc. Via AccessWire Novamind Enters New Lease Agreement Responding to Patient Demand November 12, 2021 TORONTO, ON / ACCESSWIRE / November 12, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced... From Novamind Inc. Via AccessWire Novamind Secures Insurance Coverage for Ketamine from Four Major Payors November 10, 2021 Blue Cross added to list of insurance companies covering IV ketamine treatments at Novamind TORONTO, ON / ACCESSWIRE / November 10, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... From Novamind Inc. Via AccessWire Exposures Product Safety Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading November 08, 2021 TORONTO, ON / ACCESSWIRE / November 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces... From Novamind Inc. Via AccessWire Novamind Reports FY2021 Financial Results and Operating Highlights November 05, 2021 - Industry-leading revenue, $6,069,247 in FY2021 - Total working capital of $9,680,431 to fund operations - Expanded network to six clinics and three clinical research sites - Contracted for eight... From Novamind Inc. Via AccessWire Exposures COVID-19 Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements November 04, 2021 TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc. Via AccessWire Novamind Unveils Stealth Mode Investment in Alto Neuroscience October 22, 2021 TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased... From Novamind Ventures Inc. Via AccessWire Novamind Granted DEA Licenses for Psilocybin Research October 13, 2021 Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substances TORONTO, ON / ACCESSWIRE / October 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... From Novamind Inc. Via AccessWire Novamind to Present at LD Micro and KCSA Conferences October 08, 2021 TORONTO, ON / ACCESSWIRE / October 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc. Via AccessWire Novamind Launches New Psychedelic Palliative Care Program October 07, 2021 Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illness TORONTO, ON / ACCESSWIRE / October 7, 2021 / Novamind Inc.... From Novamind Inc. Via AccessWire Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021 October 04, 2021 Chief Medical Officer will join expert panel on data and tech in psychedelic-assisted psychotherapy TORONTO, ON / ACCESSWIRE / October 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"... From Novamind Ventures Inc. Via AccessWire Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site September 30, 2021 TORONTO, ON / ACCESSWIRE / September 30, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... From Novamind Inc. Via AccessWire Novamind Announces DTC Eligibility for its Common Shares September 24, 2021 TORONTO, ON / ACCESSWIRE / September 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... From Novamind Inc. Via AccessWire Novamind to Present at Benzinga Healthcare Conference September 23, 2021 Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcare TORONTO, ON / ACCESSWIRE / September 23, 2021 / Novamind Inc.... From Novamind Inc. Via AccessWire Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF September 20, 2021 TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... From Novamind Inc. Via AccessWire Novamind to Present at Life Sciences Investor Forum September 14, 2021 TORONTO, ON / ACCESSWIRE / September 14, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... From Novamind Inc. Via AccessWire Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial September 13, 2021 Cedar Clinical Research to Host Phase III Trial for Investigational Therapy for Schizophrenia TORONTO, ON / ACCESSWIRE / September 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or... From Novamind Inc. Via AccessWire Novamind Uplists to OTCQB Venture Market September 09, 2021 TORONTO, ON / ACCESSWIRE / September 9, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... From Novamind Ventures Inc. Via AccessWire Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference September 08, 2021 TORONTO, ON / ACCESSWIRE / September 8, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is... From Novamind Inc. Via AccessWire Novamind Divests Non-Core Retreat Investment August 11, 2021 TORONTO, ON / ACCESSWIRE / August 11, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today... From Novamind Inc. Via AccessWire Novamind Strengthens Mental Health Expertise, Adds Communications Leader August 06, 2021 Samantha DeLenardo joins from CAMH, Canada's largest mental health teaching hospital and leader in mental health research TORONTO, ON / ACCESSWIRE / August 6, 2021 / Novamind Inc., (CSE:NM)(OTC... From Novamind Inc. Via AccessWire Exposures COVID-19 Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions July 29, 2021 Company executes organic growth mandate, on track to open four new clinics by Q3 2021 TORONTO, ON / ACCESSWIRE / July 29, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the... From Novamind Inc. Via AccessWire Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States July 21, 2021 Aims to increase visibility and facilitate investment for United States investors TORONTO, ON / ACCESSWIRE / July 21, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the... From Novamind Inc. Via AccessWire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.